Moderna's mRNA Technology Expands to Flu Vaccine with FDA Approval of mFlusiva

6 August 2026 at 9:56 pmHyperFast News

#mRNA vaccine #flu vaccine #Moderna #FDA approval #Covid-19 technology

Summary

The FDA has approved Moderna's mFlusiva, a new flu vaccine for adults aged 50 or older, which utilizes the same mRNA technology that was crucial in developing the Covid-19 vaccine.

Moderna's mRNA Technology Expands to Flu Vaccine with FDA Approval of mFlusiva

Related news

Select what you want to create

Image Post

Prompt to Post

Audio Post

Video Post

Multi-News Carousel

Upload and Schedule

Blog Post

AI Anchor Video

Newsroom FAQs